Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05307744

Effects of Lactobacillus Plantarum PS128 in Children With ASD

Effects of Lactobacillus Plantarum PS128 in Children With Autism Spectrum Disorder

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Chang Gung Memorial Hospital · Academic / Other
Sex
All
Age
7 Years – 12 Years
Healthy volunteers
Accepted

Summary

Autism spectrum disorder (ASD) is a neurodevelopmental disorder that can cause significant social, communication and behavioral deficits. Probiotics are regarded as active microorganisms. With sufficient amounts, probiotics can regulate intestinal flora, intestinal permeability, inflammation and antioxidant reactions in the body. These reactions may further promote health, regulate metabolic disease progression and prevent complications. Lactobacillus plantarum PS128 (PS128) was reported to be a psychobiotic in several animal and human studies which modulated the levels of neurotransmitters in different brain areas. This study is to evaluate whether the consumption of PS128 can improve the symptoms of patients with ASD. The current randomized, placebo-controlled trial was conducted to investigate the psychophysiological effects of PS128 in school children with ASD.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPS128Each PS128 capsule contained \>3 × 10\^10 colony forming units (CFU) with microcrystalline cellulose and weights 425 ± 25 mg.
OTHERPlaceboThe placebo capsules only contained 425 ± 25 mg microcrystalline cellulose.

Timeline

Start date
2022-07-15
Primary completion
2025-07-31
Completion
2026-12-31
First posted
2022-04-01
Last updated
2023-08-31

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT05307744. Inclusion in this directory is not an endorsement.